Insulin aspart

Rapid-acting insulin analog used to control blood sugar levels in people with diabetes, typically taken just before or after meals to manage post-meal blood glucose spikes. It helps glucose enter cells for energy and is marketed under brand names like NovoLog and Fiasp, offering a quicker onset of action compared to regular insulin. Insulin aspart is primarily targeted at individuals with diabetes who require fast-acting insulin to manage their blood sugar levels effectively.

Insulin aspart was discovered on August 16th 2019 and it currently has a search volume of 49.5K with a growth of +30%.